Osteocytic Connexin 43 Hemichannel Regulation of Adiposity
骨细胞连接蛋白 43 半通道对肥胖的调节
基本信息
- 批准号:10606023
- 负责人:
- 金额:$ 7.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AdipocytesAdipose tissueAftercareAgeAmericanAntibodiesBiological ProcessBiomedical EngineeringBone MarrowBone remodelingCause of DeathCell CommunicationCell SurvivalCellsCirculationCommunicationConnexin 43ConnexinsDataDiabetes MellitusDinoprostoneDiseaseDisease ProgressionDistantDominant-Negative MutationEnergy MetabolismEnvironmentEpidemicExtramedullaryFatty acid glycerol estersGlobal ChangeHealthHealthcareHeart DiseasesHematopoietic stem cellsHomeostasisIntegral Membrane ProteinKnowledgeLaboratoriesMacrophageMaintenanceMentorsMetabolicMetabolic DiseasesMetabolismMonitorMonoclonal AntibodiesMorbidity - disease rateMusMyelogenousMyeloid CellsObesityObesity EpidemicOrganOsteocytesOutcomeParacrine CommunicationPhysiologyPlayPopulationPreparationProcessProteinsRegulationResearchRoleSignal TransductionSiteSourceStrokeTestingTherapeuticTissue ExpansionTissuesTransgenic MiceWorkWritingautocrineblood glucose regulationbonebone cellcancer typecareercareer developmentcombatexperienceextracellularimprovedinsightmechanotransductionmetabolic abnormality assessmentmortalitymouse modelmutantnew therapeutic targetnovelobesity developmentresponseskillsstem cellstherapeutic targettransdifferentiation
项目摘要
PROJECT SUMMARY
Obesity is a global epidemic and a major contributor to some of the leading causes of death in the U.S., including
diabetes, heart disease, stroke, and certain types of cancer. Obesity plays a pleiotropic role in various metabolic
processes, including whole-body energy metabolism. Maintenance of whole-body homeostasis involves the
coordination of metabolic processes in multiple tissues, including adipose tissue and bone. Given its prominent
role in multiple bodily processes, recent evidence points to bone as a significant player in whole-body energy
metabolism. Myeloid-derived cells, specifically macrophages, that have been identified as a source of
extramedullary adipose tissue, arise from hematopoietic stem cells originating from the bone marrow. Osteocytes
comprise >90% of bone cells, are mechanosensors, and orchestrators of the bone remodeling process.
Osteocytic connexin 43 (Ocy Cx43) is a transmembrane protein expressed in bone that forms hemichannels
(HCs) that facilitate the communication of cells among themselves and with their environment. The postulation
that Ocy Cx43 may have a key role in the modulation of adipose tissue, and consequently metabolism and
disease progression, has never been investigated. By using transgenic mice expressing dominant-negative Cx43
mutants in osteocytes or monoclonal antibodies that open/close Cx43 HCs, our laboratory has shown that Ocy
Cx43 HCs are responsible for changes in adipose formation, in correlation with modulation in myeloid cell
populations. Thus, altering Ocy Cx43 activity could be a new therapeutic target for the treatment of metabolic
diseases, including obesity. This research effort aims to understand how Ocy Cx43 HCs can improve metabolic
health by reducing fat through myeloid cell regulation and evaluate this as a unique target for combatting obesity.
This information will identify new therapeutic targets for obesity and metabolic diseases. A better understanding
of the underlying mechanism connecting these tissues/cells will give us the ability to manipulate these
environments to improve systemic energy metabolism and glucose homeostasis, and to combat fat formation.
项目概要
肥胖是一种全球流行病,也是美国一些主要死亡原因的主要原因,包括
糖尿病、心脏病、中风和某些类型的癌症。肥胖在多种代谢中发挥着多效性作用
过程,包括全身能量代谢。维持全身稳态涉及
协调多个组织的代谢过程,包括脂肪组织和骨骼。鉴于其突出的
在多个身体过程中发挥作用,最近的证据表明骨骼在全身能量中发挥着重要作用
代谢。骨髓来源的细胞,特别是巨噬细胞,已被确定为
髓外脂肪组织由源自骨髓的造血干细胞产生。骨细胞
构成超过 90% 的骨细胞,是机械传感器和骨重塑过程的协调者。
骨细胞连接蛋白 43 (Ocy Cx43) 是一种在骨中表达的跨膜蛋白,可形成半通道
(HC)促进细胞之间以及与环境的沟通。假设
Ocy Cx43 可能在脂肪组织的调节以及由此产生的代谢和
疾病进展,从未被研究过。通过使用表达显性失活 Cx43 的转基因小鼠
骨细胞或单克隆抗体中的突变体可打开/关闭 Cx43 HC,我们的实验室已证明 Ocy
Cx43 HC 负责脂肪形成的变化,与骨髓细胞的调节相关
人口。因此,改变 Ocy Cx43 活性可能成为治疗代谢性疾病的新治疗靶点。
疾病,包括肥胖。这项研究工作旨在了解 Ocy Cx43 HC 如何改善代谢
通过骨髓细胞调节减少脂肪来保持健康,并将其评估为对抗肥胖的独特目标。
这些信息将确定肥胖和代谢疾病的新治疗靶点。更好的理解
连接这些组织/细胞的潜在机制将使我们能够操纵这些组织/细胞
改善全身能量代谢和葡萄糖稳态,并对抗脂肪形成的环境。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Francisca Maria Acosta其他文献
Francisca Maria Acosta的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
YTHDC1调控棕色脂肪组织大小、发育和能量代谢的作用机制研究
- 批准号:32371198
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
糖尿病脂肪组织中SIRT3表达降低进而上调外泌体miR-146b-5p促进肾小管脂毒性的机制研究
- 批准号:82370731
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于ADPN-Cer轴的柑橘黄酮调控能量负平衡奶牛脂肪组织脂解的分子机制
- 批准号:32302767
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Acvrl1调控脂肪组织巨噬细胞M1/M2极化改善肥胖的机制研究
- 批准号:82300973
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ANGPTLs基因及其蛋白表达水平调控内脏脂肪组织影响健康衰老表型的前瞻性队列研究
- 批准号:82373661
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Multiparametric PET/MRI Assessment of Mast Cell Stabilization Effects on Inflammaging and Glucose Utilization in Infarcted Myocardium
多参数 PET/MRI 评估肥大细胞稳定对梗塞心肌炎症和葡萄糖利用的影响
- 批准号:
10650676 - 财政年份:2023
- 资助金额:
$ 7.22万 - 项目类别:
New Approaches to the Evaluation and Treatment of Acromegaly
肢端肥大症评估和治疗的新方法
- 批准号:
9924534 - 财政年份:2017
- 资助金额:
$ 7.22万 - 项目类别:
New Approaches to the Evaluation and Treatment of Acromegaly
肢端肥大症评估和治疗的新方法
- 批准号:
9750716 - 财政年份:2017
- 资助金额:
$ 7.22万 - 项目类别:
Sequestration and deactivation of anthracycline by adipocytes in the leukemia microenvironment
白血病微环境中脂肪细胞对蒽环类药物的封存和失活
- 批准号:
9752263 - 财政年份:2017
- 资助金额:
$ 7.22万 - 项目类别: